Twinbeech Capital LP Repligen Corp Transaction History

Twinbeech Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $1.77 Million - $2.16 Million	10,379 New	10,379 $1.91 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $1.54 Million - $2.01 Million	11,144 New	11,144 $1.58 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $7.95 Million - $12.7 Million	49,554 New	49,554 $9.27 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $1.12 Million - $1.57 Million	-7,577 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $928,258 - $1.2 Million	7,577 New	7,577 $1.12 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.